|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Multiple Sclerosis
|
NINDS
|
7R01NS046678-04
|
|
Genetic and MRI correlates of humoral immunity to myelin
|
GENAIN, CLAUDE
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
CA
|
$389,586
|
|
Multiple Sclerosis
|
NINDS
|
5K24NS044250-06
|
|
Immunopathogenesis of Multiple Sclerosis
|
RACKE, MICHAEL
|
OHIO STATE UNIVERSITY
|
OH
|
$128,911
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS052259-04
|
|
Actomyosin motors and Mechanism of Myelin Formation
|
MELENDEZ-VASQUEZ, CARMEN
|
HUNTER COLLEGE
|
NY
|
$266,629
|
|
Multiple Sclerosis
|
NINDS
|
5R21NS054109-02
|
|
Molecular Probes for In Vivo MR Studies of Myelin
|
WANG, YANMING
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$1
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI059089-04
|
|
Neuroimmune Communication at the Blood Brain Barrier
|
QUAN, NING
|
OHIO STATE UNIVERSITY
|
OH
|
$278,119
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI023598-22
|
|
Role of DAF in the Complement Cascade
|
MEDOF, M
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$430,317
|
|
Multiple Sclerosis
|
NINDS
|
5K08NS048204-04
|
|
The Pathophysiology of Conduction Block in HNPP
|
LI, JUN
|
WAYNE STATE UNIVERSITY
|
MI
|
$122,079
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI064320-03
|
|
Migration Inhibitory Factor in the Progression of EAE
|
WHITACRE, CAROLINE
|
OHIO STATE UNIVERSITY
|
OH
|
$356,016
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI064177-04
|
|
TCR Crossreactivity in autoimmune Diseases
|
WUCHERPFENNIG, KAI
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$391,041
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI063496-03
|
|
Immune Regulation by Gadd45b and Gadd45g
|
LU, BINFENG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$301,640
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI041747-10
|
|
Autoimmune Disease and Neonatal Tolerance
|
TEUSCHER, CORY
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$277,004
|
|
Multiple Sclerosis
|
NIMH
|
5K23MH069702-03
|
|
Depression and Cognitive Impairment in Transverse Myelitis
|
KAPLIN, ADAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$183,276
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI037562-12
|
|
IMMUNOLOGIC MECHANISMS THAT PREVENT AUTOIMMUNITY
|
CANTOR, HARVEY
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$407,216
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS055167-02
|
|
Mechanisms of EAE Resistance and Development of Chronic Relapsing Disease
|
TSE, HARLEY
|
WAYNE STATE UNIVERSITY
|
MI
|
$296,297
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI054912-02
|
|
Immune Tolerance Mediated by Negative Costimulatory Molecules
|
DONG, CHEN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$377,685
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI059709-04
|
|
Immunomodulation of inflammatory disease by atorvastatin
|
ZAMVIL, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$417,044
|
|
Multiple Sclerosis
|
NIAID
|
5R37AI038310-14
|
|
In Vivo Function of the B7 Family of Costimulators
|
SHARPE, ARLENE
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$403,644
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS053905-02
|
|
PLP alternative splicing and oligodendrocyte differentiation
|
CAMBI, FRANCA
|
UNIVERSITY OF KENTUCKY
|
KY
|
$320,469
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS055337-02
|
|
Treatment of Demyelinating Disease with HSP90 Inhibitors
|
FEINSTEIN, DOUGLAS
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$305,156
|
|
Multiple Sclerosis
|
NIDDK
|
5R01DK060027-07
|
|
aire a zinc-finger protein that controls autoimmunity
|
MATHIS, DIANE
|
JOSLIN DIABETES CENTER
|
MA
|
$323,823
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS027336-18
|
|
Genetic Analysis of Glycan Function in Myelinating Cells
|
POPKO, BRIAN
|
UNIVERSITY OF CHICAGO
|
IL
|
$334,382
|
|
Multiple Sclerosis
|
NCI
|
5R01CA114587-04
|
|
Neuroinflammation in CNS Radiation Injury: IL-1 & COX-2
|
O'BANION, MICHAEL
|
UNIVERSITY OF ROCHESTER
|
NY
|
$292,135
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS050220-04
|
|
Role of three novel CAMs in myelinating glia
|
PELES, ELIOR
|
WEIZMANN INSTITUTE OF SCIENCE
|
ISRAEL
|
$142,085
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS048411-04
|
|
Mechanisms of CD4+CD25+ T Regulatory Cells in EAE
|
MILLER, STEPHEN
|
NORTHWESTERN UNIVERSITY
|
IL
|
$305,492
|
|
Multiple Sclerosis
|
NINDS
|
5F32NS049744-03
|
|
Analysis of node of Ranvier development in the zebrafish
|
VOAS, MATTHEW
|
STANFORD UNIVERSITY
|
CA
|
$52,048
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS038236-07
|
|
Processing and degradation of proteolipid protein
|
SKOFF, ROBERT
|
WAYNE STATE UNIVERSITY
|
MI
|
$328,805
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS047578-03
|
|
Mechanisms of mast cell influence on EAE disease course
|
BROWN, MELISSA
|
NORTHWESTERN UNIVERSITY
|
IL
|
$259,548
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS039940-09
|
|
Activation of NF-kB in glial cells and CNS of EAE
|
PAHAN, KALIPADA
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$292,063
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI069289-03
|
|
Autoimmune encephalomyelitis and Bcl-2- interacting mediator
|
CHEN, YOUHAI
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$375,067
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS043174-06
|
|
Axonal alterations in demyelinating diseases
|
SCHERER, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$344,531
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS052177-02
|
|
Steroid resistance: Experimental Autoimmune Encephalomyelitis/Multiple Sclerosis
|
FORSTHUBER, THOMAS
|
UNIVERSITY OF TEXAS SAN ANTONIO
|
TX
|
$278,578
|
|
Multiple Sclerosis
|
NIAAA
|
5R01AA013740-05
|
|
Ethanol Effects on PKC in Oligodendrocytes.
|
ELLINGSON, JOHN
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$269,815
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS051623-03
|
|
Novel MRI and 1H-MRS markers in Primary Progressive MS
|
INGLESE, M
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$369,223
|
|
Multiple Sclerosis
|
NINDS
|
5K08NS050409-05
|
|
Oligodendrocyte response to interferon-gamma
|
BALABANOV, ROUMEN
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$146,428
|
|
Multiple Sclerosis
|
NINDS
|
5U01NS045719-05
|
|
Combination Therapy in Multiple Sclerosis
|
LUBLIN, FRED
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$9,090,524
|
|
Multiple Sclerosis
|
NINDS
|
5K24NS051400-03
|
|
Chemokine Regulation on Central Nervous System Inflammation in Multiple Sclerosis
|
RANSOHOFF, RICHARD
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$169,668
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS040751-07
|
|
Genetic Control of Schwann Cell Differentiation
|
BERMINGHAM, JOHN
|
MC LAUGHLIN RESEARCH INSTITUTE
|
MT
|
$359,844
|
|
Multiple Sclerosis
|
NINDS
|
5R21NS055276-02
|
|
Guidance of Oligodendrocyte Processes: The Role of Local Protein Synthesis
|
FUSS, BABETTE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$162,969
|
|
Multiple Sclerosis
|
NINDS
|
5R21NS057297-02
|
|
Imaging Cytokine Receptors in the CNS
|
PENA, LOUIS
|
BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB
|
NY
|
$251,868
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI071233-02
|
|
Interferon actions and autoimmune disorders
|
DAVID, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$372,055
|
|
Multiple Sclerosis
|
NINDS
|
1R01NS060808-01
|
|
Role of glia in sculpting synpatic fields during development and plasticity
|
FREEMAN, MARC
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$355,469
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI041123-07
|
|
Mucosal Immunity Elicited by Salmonella Vaccine Delivery
|
PASCUAL, DAVID
|
MONTANA STATE UNIVERSITY (BOZEMAN)
|
MT
|
$296,143
|
|
Multiple Sclerosis
|
NIAID
|
1R01AI076544-01
|
|
The Identification of Risk Factors for the Complex MS Phenotype
|
BARCELLOS, LISA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$737,415
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS037958-10
|
|
Picornavirus-host Cell Interactions and Disease
|
ROOS, RAYMOND
|
UNIVERSITY OF CHICAGO
|
IL
|
$334,382
|
|
Multiple Sclerosis
|
NINDS
|
5F31NS054395-03
|
|
The Role of Mast in a Model of Relapsing-Remitting Multiple Sclerosis
|
SAYED, BLAYNE
|
NORTHWESTERN UNIVERSITY
|
IL
|
$28,777
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS054042-03
|
|
Extracellular matrix regulation of myelination
|
COLOGNATO, HOLLY
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$372,571
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI072737-11
|
|
MECHANISMS OF TOLERANCE AND IMMUNITY TO CENTRAL NERVOUS SYSTEM ANTIGENS
|
GOVERMAN, JOAN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$383,116
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS041249-07
|
|
Chemokines and Viral-Induced Neurologic Disease
|
LANE, THOMAS
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$297,138
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS051282-08
|
|
Mechanism of Neuropathy Target Esterase/swisscheese
|
CHAO, MOSES
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$370,561
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS048252-04
|
|
K-Channels in Lymphocyte Function and Autoimmunity
|
CHANDY, GEORGE
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$329,541
|
|
Multiple Sclerosis
|
NINDS
|
1K24NS060950-01
|
|
Translational applications of Progressive Multifocal Leukoencephalopathy studies
|
KORALNIK, IGOR
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$136,849
|
|
Multiple Sclerosis
|
NINDS
|
1R01NS061014-01
|
|
Histamine Receptor Signaling in CNS Autoimmune Disease
|
TEUSCHER, CORY
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$625,711
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI050839-07
|
|
The Effect of Sex Chromosomes on Immune Responses
|
VOSKUHL, RHONDA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$359,276
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS054194-03
|
|
Noninvasive Quantification of Axon Damage in EAE and MS
|
SONG, SHENG-KWEI
|
WASHINGTON UNIVERSITY
|
MO
|
$368,980
|
|
Multiple Sclerosis
|
NCCAM
|
1K23AT004433-01
|
|
SAFETY AND NEUROPROTECTIVE EFFECTS OF POLYPHENON E IN MULTIPLE SCLEROSIS
|
LOVERA, JESUS
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$102,411
|
|
Multiple Sclerosis
|
NINDS
|
5R21NS055783-02
|
|
Forced Differentiation of CNS Neural Precursors in vitro and in vivo
|
PLEASURE, SAMUEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$168,757
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS041549-06
|
|
Antigen Identification in Chronic Inflammatory CNS Disease
|
BURGOON, MARK
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$336,875
|
|
Multiple Sclerosis
|
NHLBI
|
5R01HL051018-11
|
|
Proteinase Modulation During T-Cell Endothelial Adhesion
|
MADRI, JOSEPH
|
YALE UNIVERSITY
|
CT
|
$413,125
|
|
Multiple Sclerosis
|
NICHD
|
1R03HD057560-01
|
|
Early intervention to restore OL and myelin development in leukodystrophy model
|
DE VELLIS, JEAN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$77,000
|
|
Multiple Sclerosis
|
NIGMS
|
1R01GM083274-01
|
|
Using Nanomaterials to Inhibit Mast Cell/Basophil-Associated Disease
|
KEPLEY, CHRISTOPHER
|
LUNA INNOVATIONS, INC.
|
VA
|
$297,814
|
|
Multiple Sclerosis
|
NIBIB
|
5R01EB007243-02
|
|
Multimodal multiphoton imaging of nervous system ex vivo and in vivo
|
CHENG, JI-XIN
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
IN
|
$342,882
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI043960-08
|
|
Novel MHC Class II Constructs For Treatment of EAE
|
BURROWS, GREGORY
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$366,733
|
|
Multiple Sclerosis
|
NIEHS
|
5R01ES006387-15
|
|
Adduct Formation in the Toxicity of Dithiocarbamates
|
VALENTINE, WILLIAM
|
VANDERBILT UNIVERSITY
|
TN
|
$386,681
|
|
Multiple Sclerosis
|
NINDS
|
1R01NS056074-01A1
|
|
Astrocyte regulation of CNS remyelination
|
JOHN, GARETH
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$237,300
|
|
Multiple Sclerosis
|
NINDS
|
5K01NS054096-03
|
|
Genetic Elements that Influence Susceptibility to CNS Autoimmunity
|
ANDERSON, ANA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$177,930
|
|
Multiple Sclerosis
|
NIAID
|
1R01AI073726-01A1
|
|
MOG-Specific T Cell Trafficking in the Central Nervous System
|
GOVERMAN, JOAN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$385,375
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS051470-04
|
|
INTERACTIONS OF FIBRINOGEN WITH p75NTR
|
AKASSOGLOU, KATERINA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$10,743
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS056427-02
|
|
Characterization of Sox17 as a Regulator of Oligodendrocyte Cell Differentiation
|
GALLO, VITTORIO
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$363,125
|
|
Multiple Sclerosis
|
NINDS
|
2R01NS035685-10A2
|
|
Role of B7 costimulation in induction and regulation of EAE
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$431,094
|
|
Multiple Sclerosis
|
NINDS
|
2R01NS046635-03
|
|
Prospective Study of Vitamin D and Multiple Sclerosis
|
ASCHERIO, ALBERTO
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$515,014
|
|
Multiple Sclerosis
|
NINDS
|
1R01NS055997-01A2
|
|
Autoantibody Arrays Guide Tolergenic Therapy for Multiple Sclerosis
|
STEINMAN, LAWRENCE
|
STANFORD UNIVERSITY
|
CA
|
$317,600
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS026001-19
|
|
Regulation of Schwann cell ensheathment and myelination by type III Neuregulin 1
|
SALZER, JAMES
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$369,223
|
|
Multiple Sclerosis
|
NINDS
|
2R01NS029029-16A1
|
|
Quantitative MR Imaging and Proton Spectroscopy in MS
|
GROSSMAN, ROBERT
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$685,462
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS047661-04
|
|
REGULATION OF EAE WITH RECOMBINANT TCR LIGANDS
|
VANDENBARK, ARTHUR
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$336,724
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS021913-31
|
|
Molecular Basis of TMEV-induced Demyelinating Disease
|
LIPTON, HOWARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$419,914
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS046662-05
|
|
Encephalitogenic T Cell Regulation of Microglial Cells
|
DITTEL, BONNIE
|
BLOODCENTER OF WISCONSIN, INC.
|
WI
|
$299,730
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS048249-05
|
|
The regulation of myelination by the p75-NFkB pathway
|
CARTER, BRUCE
|
VANDERBILT UNIVERSITY
|
TN
|
$297,983
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS023221-21
|
|
REGULATION OF AUTOIMMUNITY WITH T CELL RECEPTOR PEPTIDES
|
VANDENBARK, ARTHUR
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$350,713
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS042304-07
|
|
Nogo Receptor in Adult Central Nervous System Plasticity and Regeneration
|
STRITTMATTER, STEPHEN
|
YALE UNIVERSITY
|
CT
|
$361,485
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS056380-02
|
|
The role of mouse ARL13B in cell diversification during spinal cord development
|
CASPARY, TAMARA
|
EMORY UNIVERSITY
|
GA
|
$334,688
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS056097-02
|
|
Role of QKI in oligodendroglia and myelin development
|
FENG, YUE
|
EMORY UNIVERSITY
|
GA
|
$334,688
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI053824-06
|
|
Regulation of Gender Dependent EAE Susceptibility
|
STOHLMAN, STEPHEN
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$287,421
|
|
Multiple Sclerosis
|
NIAID
|
1R21AI067474-01A2
|
|
Human Keratin (K14)-MBP/MBP-TCR Transgenic Animal Model
|
ITO, KOUICHI
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
NJ
|
$184,360
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI045816-09
|
|
M. LEPRAE-INDUCED CONTACT-DEPENDENT DEMYELINATION
|
RAMBUKKANA, ANURA
|
ROCKEFELLER UNIVERSITY
|
NY
|
$314,396
|
|
Multiple Sclerosis
|
NEI
|
5K24EY018136-02
|
|
Novel visual outcome measures in optic neuritis and multiple sclerosis
|
BALCER, LAURA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$155,279
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS056176-03
|
|
Attenuation of Axonal Damage and Neuronal Death in EAE
|
BANIK, NAREN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$354,415
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS041088-08
|
|
CALPAIN ACTIVATION OF T CELLS IN DEMYELINATING DISEASE
|
BANIK, NAREN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$318,974
|
|
Multiple Sclerosis
|
NIAID
|
1R01AI067472-01A2
|
|
MEMORY T CELLS IN EAE
|
KHOURY, SAMIA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$395,256
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI056153-05
|
|
TREATMENT OF AUTOIMMUNITY WITH RECEPTOR-MODIFIED T CELLS
|
GEIGER, TERRENCE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$348,812
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS049136-03
|
|
Mechanisms of Neuropathic Pain in Demylenated Nerves
|
WHITE, FLETCHER
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$259,548
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI071448-02
|
|
Impact of IFN-gamma on Neural Stem Cell Repair Potential in EAE
|
KHOURY, SAMIA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$326,703
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS055083-02
|
|
Gray vs. white matter brain atrophy in multiple sclerosis
|
BAKSHI, ROHIT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$376,430
|
|
Multiple Sclerosis
|
NINDS
|
5K08NS055061-03
|
|
Macrophage and Microglial Activation in Glioma-Associated Inflammation
|
GUPTA, NALIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$161,406
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS056417-02
|
|
Signaling pathways controlling myelination
|
MACKLIN, WENDY
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$337,969
|
|
Multiple Sclerosis
|
NINDS
|
5F30NS049808-03
|
|
Anatomical Distribution of Pathology in MS
|
HOLLAND, CHRISTOPHER
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$48,787
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS032129-13
|
|
T cell Function in Murine Model of Multiple Sclerosis
|
RODRIGUEZ, MOSES
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$323,343
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS039293-08
|
|
REMYELINATION AND AXON INTEGRITY IN CHRONIC DEMYELINATION
|
ARMSTRONG, REGINA
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$294,500
|
|
Multiple Sclerosis
|
NCI
|
5R01CA100660-05
|
|
Self-glycolipid-reactive T cells: repertoire & function
|
KUMAR, VIPIN
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
CA
|
$353,768
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI052306-07
|
|
Role of PGE2 in CNS and peripheral autoimmune disorders
|
GANEA, DOINA
|
TEMPLE UNIVERSITY
|
PA
|
$347,274
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS035884-11
|
|
Molecular Basis of Neuron-Gila Interactions in the CNS
|
CORFAS, GABRIEL
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$389,810
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI073542-02
|
|
Trafficking and the role of myelin specific Regulatory T cells in EAE
|
OUKKA, MOHAMED
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$355,019
|
|
Multiple Sclerosis
|
NINDS
|
2R44NS041692-04A2
|
|
CD24 as Therapeutic Target for Multiple Sclerosis-phase II Competing Renewal
|
ZHENG, XINCHENG
|
ONCOIMMUNE, LTD
|
OH
|
$469,280
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS039962-09
|
|
Molecular Determinants of Axonal Regeneration
|
STRITTMATTER, STEPHEN
|
YALE UNIVERSITY
|
CT
|
$358,502
|
|
Multiple Sclerosis
|
NICHD
|
5R01HD041590-07
|
|
Genetic Control of Myelination by EGR2 and NAB proteins
|
SVAREN, JOHN
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$296,731
|
|
Multiple Sclerosis
|
NIBIB
|
5R01EB001452-04
|
|
Quantitative MT imaging development and application
|
GOCHBERG, DANIEL
|
VANDERBILT UNIVERSITY
|
TN
|
$325,576
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI044880-09
|
|
Genetic Basis for susceptibility to Experimental Autoimmune Encephalomyelitis
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$369,467
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS040511-09
|
|
Oligodendrocyte Lineage Gene Function in the CNS
|
ROWITCH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$450,697
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS049510-04
|
|
Genetic and non-genetic risk factors in MS
|
BARCELLOS, LISA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$554,551
|
|
Multiple Sclerosis
|
NINDS
|
1F32NS059205-01A1
|
|
The Role of Notch Signaling in Experimental Autoimmune Encephalomyelitis (EAE)
|
ELYAMAN, WASSIM
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$54,842
|
|
Multiple Sclerosis
|
NICHD
|
5R01HD045798-05
|
|
Improving Learning in MS: A Randomized Clinical Trial
|
CHIARAVALLOTI, NANCY
|
KESSLER MEDICAL REHAB RES & EDUC CORP
|
NJ
|
$649,623
|
|
Multiple Sclerosis
|
NIGMS
|
1F32GM083567-01
|
|
Studying the dynamics of protein allostery with path-based Markov state models
|
PAN, ALBERT
|
UNIVERSITY OF CHICAGO
|
IL
|
$49,646
|
|
Multiple Sclerosis
|
NINDS
|
5F31NS052057-03
|
|
In vivo MRI of spinal cord lesions in EAE mice
|
BUDDE, MATTHEW
|
WASHINGTON UNIVERSITY
|
MO
|
$6,770
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS046630-05
|
|
A Whole Genome Admixture Scan for Multiple Sclerosis
|
REICH, DAVID
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$559,571
|
|
Multiple Sclerosis
|
NINDS
|
5K02NS047457-05
|
|
CD8 T Lymphocyte Regulation of EAE Disease Phenotype
|
CARRITHERS, MICHAEL
|
YALE UNIVERSITY
|
CT
|
$118,881
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS049175-05
|
|
Biochemical Basis of Axonal & Myelin Injury In Head Trauma
|
WANG, KEVIN
|
BANYAN BIOMARKERS, INC.
|
FL
|
$441,401
|
|
Multiple Sclerosis
|
NINDS
|
5R37NS038186-10
|
|
Molecular Mechanisms of Schwann Cell Myelination
|
TRAPP, BRUCE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$426,080
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI061818-05
|
|
Mechanisms of action IL-23 in relapsing demyelination
|
ROSTAMI, ABDOLMOHAMAD
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$365,089
|
|
Multiple Sclerosis
|
NINDS
|
5R03NS056228-02
|
|
Brain plasticity/ repair genes and neuroimaging in MS
|
WISHART, HEATHER
|
DARTMOUTH COLLEGE
|
NH
|
$79,950
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS040085-07
|
|
Tolerance induced by IV MBP in EAE
|
ROSTAMI, ABDOLMOHAMAD
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$376,263
|
|
Multiple Sclerosis
|
NINDS
|
5K23NS045830-04
|
|
Neural Mechanisms of Cognitive and Motor Symptoms in MS
|
WISHART, HEATHER
|
DARTMOUTH COLLEGE
|
NH
|
$178,740
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS056234-03
|
|
Effects of hyaluronan on neural stem cell homing and differentiation
|
SHERMAN, LARRY
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$317,370
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS047592-04
|
|
Evaluation of Spinal Cord White Matter Injury Using DTI
|
SONG, SHENG-KWEI
|
WASHINGTON UNIVERSITY
|
MO
|
$335,479
|
|
Multiple Sclerosis
|
NIDA
|
5R01DA014486-07
|
|
Cannabinoid Signaling System in Microglial Cells
|
STELLA, NEPHI
|
UNIVERSITY OF WASHINGTON
|
WA
|
$305,760
|
|
Multiple Sclerosis
|
NCCAM
|
5R21AT003605-02
|
|
Mechanisms and effects of phytoestrogen treatment in autoimmune optic neuritis
|
STOKELY, MARTHA
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
TX
|
$211,680
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS050520-04
|
|
Serial Brain 3D 1H MR Spectroscopy in Multiple Sclerosis
|
GONEN, ODED
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$585,624
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI067750-03
|
|
Homing and Homeostasis of Regulatory T cells
|
CAMPBELL, DANIEL
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$435,793
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS026543-19
|
|
Immunoregulation and Pathology of Chronic-Relapsing EAE
|
MILLER, STEPHEN
|
NORTHWESTERN UNIVERSITY
|
IL
|
$330,313
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS045445-07
|
|
IMMUNOREGULATORY EFFECTS OF ESTROGEN IN EAE
|
OFFNER, HALINA
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$324,628
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI065463-02
|
|
AUTOREACTIVE CD8+ T CELLS IN MULTIPLE SCLEROSIS
|
KARANDIKAR, NITIN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$308,034
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS049885-05
|
|
Mechanisms of SCI Recovery after hCNS Stem Cell Grafts
|
ANDERSON, AILEEN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$267,506
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS047467-04
|
|
Molecular Epidemiology of EBV and Multiple Sclerosis
|
ASCHERIO, ALBERTO
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$566,729
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS037406-09
|
|
Modulation of Autoreactive T Cells
|
ZAGHOUANI, HABIB
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$287,130
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS049577-03
|
|
Genetic Determinants of Pathologic Heterogeneity in MS
|
LUCCHINETTI, CLAUDIA
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$323,343
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI059829-05
|
|
Immunogenetic Studies of Autoimmune Disease
|
BARCELLOS, LISA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$352,570
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS019943-22
|
|
Oligodendrocyte ontogeny and differentiation
|
BARBARESE, ELISA
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$323,750
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS036592-11
|
|
Role of CTL escape mutants in MHV-induced demyelination
|
PERLMAN, STANLEY
|
UNIVERSITY OF IOWA
|
IA
|
$299,835
|
|
Multiple Sclerosis
|
NINDS
|
7R01NS042925-06
|
|
Histone deacetylation in oligodendrocyte differentiation
|
CASACCIA-BONNEFIL, PATRIZIA
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$370,781
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS055256-03
|
|
Pathogenesis of Myelin Protein Zero Neuropathies in Transgenic Mice
|
WRABETZ, LAWRENCE
|
ISTITUTO SCIENTIFICO SAN RAFFAELE
|
ITALY
|
$235,953
|
|
Multiple Sclerosis
|
NINDS
|
5R37NS030843-17
|
|
T cell response to myelin proteolipid protein
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$365,918
|
|
Multiple Sclerosis
|
NIMH
|
5R01MH072528-05
|
|
Pathogenesis of leukoencephalopathies in HIV+ patients
|
FERRANTE, PASQUALE
|
SAINT JOSEPH HOSPITAL
|
ITALY
|
$230,408
|
|
Multiple Sclerosis
|
NHLBI
|
5R01HL031809-25
|
|
LYSOLIPID PHOSPHATE REGULATION OF LYMPHOCYTE FUNCTIONS
|
GOETZL, EDWARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$323,210
|
|
Multiple Sclerosis
|
FIC
|
1R21NS058293-01A1
|
|
In vivo Imaging of Brain Damage in HTLV-I Associated Tropical Spastic Paraparesis
|
MAINERO, CATERINA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$5,000
|
|
Multiple Sclerosis
|
NINDS
|
1R21NS058293-01A1
|
|
In vivo Imaging of Brain Damage in HTLV-I Associated Tropical Spastic Paraparesis
|
MAINERO, CATERINA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$155,813
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS044916-08
|
|
Neuroglial interactions at the node of Ranvier
|
RASBAND, MATTHEW
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$335,781
|
|
Multiple Sclerosis
|
NINDS
|
5R03NS055871-02
|
|
Functional effects of B cells activated by spinal cord injury in mice
|
ANKENY, DANIEL
|
OHIO STATE UNIVERSITY
|
OH
|
$75,000
|
|
Multiple Sclerosis
|
NINDS
|
5K99NS057944-02
|
|
A role for EGF receptor signaling in oligodendrocyte development and repair
|
AGUIRRE, ADAN
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$90,000
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS037475-08
|
|
Pathology of dysmyelination and demyelination
|
ROSENBLUTH, JACK
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$333,375
|
|
Multiple Sclerosis
|
NIBIB
|
5R01EB007258-02
|
|
Human Brain Vascular Phenotyping with High-Field MRI:Water Permeability Mapping
|
ROONEY, WILLIAM
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$305,613
|
|
Multiple Sclerosis
|
FIC
|
1R03TW007947-01A1
|
|
PD-Ialpha/ATX's role for forebrain oligodendrocyte specification and migration
|
FUSS, BABETTE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$37,412
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS054734-02
|
|
Functional Analysis of Myelin Inhibitors in Spinal Axon Regeneration Failure
|
ZHENG, BINHAI
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$337,969
|
|
Multiple Sclerosis
|
NHLBI
|
7R01HL046849-19
|
|
Roles of Endothelial PECAM-1 in Leukocyte Transmigration
|
MULLER, WILLIAM
|
NORTHWESTERN UNIVERSITY
|
IL
|
$322,145
|
|
Multiple Sclerosis
|
NIAID
|
5R13AI065123-04
|
|
FASEB Summer Conference on 'Autoimmunity'
|
VON HERRATH, MATTIAS
|
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
|
MD
|
$1
|
|
Multiple Sclerosis
|
NINDS
|
5R13AI065123-04
|
|
FASEB Summer Conference on 'Autoimmunity'
|
VON HERRATH, MATTIAS
|
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
|
MD
|
$5,000
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS044905-05
|
|
CNS Pathobiology of IFN-inducible non-ELR CXC Chemokines
|
CAMPBELL, IAIN
|
UNIVERSITY OF SYDNEY
|
AUSTRA
|
$236,808
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS052173-03
|
|
Role of HLA class II genes in demyelination
|
DAVID, CHELLA
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$194,006
|
|
Multiple Sclerosis
|
NIAID
|
2P01AI045757-10
|
0004
|
Antigen Presentation to Self-reactive T Cells in Human Autoimmune Diseases
|
WUCHERPFENNIG, KAI
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$914,628
|
|
Multiple Sclerosis
|
NIAID
|
2P01AI045757-10
|
0005
|
Peripheral Tolerance Induction by Lymph Node Stromal Cells and Dendritic Cells
|
TURLEY, SHANNON
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$127,635
|
|
Multiple Sclerosis
|
NIAID
|
2P01AI045757-10
|
0006
|
Antigen Presentation by B Cells in T Cell Mediated Autoimmunity
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$213,210
|
|
Multiple Sclerosis
|
NIAID
|
2P01AI045757-10
|
0007
|
B Cells as Antigen Presenting Cells in Human Autoimmune Diseases
|
HAFLER, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$285,400
|
|
Multiple Sclerosis
|
NIAID
|
2P01AI045757-10
|
9001
|
Novel Tools for Immune Monitoring in Autoimmune Diseases
|
WUCHERPFENNIG, KAI
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$69,179
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS040460-09
|
|
A Virus-induced Molecular Mimicry Model of MS
|
MILLER, STEPHEN
|
NORTHWESTERN UNIVERSITY
|
IL
|
$280,116
|
|
Multiple Sclerosis
|
NINR
|
5R01NR003195-14
|
|
Health Promotion and Quality of Life in Chronic Illness
|
STUIFBERGEN, ALEXA
|
UNIVERSITY OF TEXAS AUSTIN
|
TX
|
$310,513
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI044970-09
|
|
Biology of decay accelerating factor
|
SONG, WENCHAO
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$331,721
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS030871-15
|
|
Pathogenesis and Immunoregulation of PLP-Induced R-EAE
|
MILLER, STEPHEN
|
NORTHWESTERN UNIVERSITY
|
IL
|
$325,869
|
|
Multiple Sclerosis
|
NIEHS
|
5R21ES015564-02
|
|
Study of Environmental Risk Factors of MS After Conditioning on Genetic Factor
|
ROLAK, LOREN
|
MARSHFIELD CLINIC RESEARCH FOUNDATION
|
WI
|
$147,000
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS041078-08
|
|
PROTEOMIC MAPPING OF MYELIN AND ITS MEMBRANE SUBDOMAINS
|
BANSAL, RASHMI
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$430,122
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS029818-16
|
|
Cellular Mechanisms for Oligodendrocyte Myelination
|
TRAPP, BRUCE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$337,544
|
|
Multiple Sclerosis
|
NIAID
|
1R21AI078286-01
|
|
CD24 and thymic generation of myelin antigen specific T cells
|
BAI, XUE-FENG
|
OHIO STATE UNIVERSITY
|
OH
|
$225,000
|
|
Multiple Sclerosis
|
NINDS
|
5F31NS056574-02
|
|
Role of sPLA2 in Spinal Cord Injury and Demyelination
|
TITSWORTH, WILLIAM
|
UNIVERSITY OF LOUISVILLE
|
KY
|
$25,798
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS049477-04
|
|
A Haplotype Map for Multiple Sclerosis
|
HAUSER, STEPHEN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$1,855,158
|
|
Multiple Sclerosis
|
NINDS
|
5R43NS059219-02
|
|
Feasibility Study of Novel Drug Target for Multiple Sclerosis
|
THACHER, SCOTT
|
ORPHAGEN PHARMACEUTICALS
|
CA
|
$210,190
|
|
Multiple Sclerosis
|
NIGMS
|
5R01GM076709-02
|
|
Myelin Composition Influence on Bilayer Interactions in Multiple Sclerosis
|
ISRAELACHVILI, JACOB
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
CA
|
$271,905
|
|
Multiple Sclerosis
|
NINDS
|
1K24NS062117-01
|
|
Treatment of Multiple Sclerosis with Sex Hormones
|
VOSKUHL, RHONDA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$140,052
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS050742-04
|
|
Mechanisms of Death and Survival in Oligodendroglia
|
WOOD, TERESA
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$331,218
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI065972-03
|
|
The cell biology of Theiler's virus persistence in CNS
|
KIRKEGAARD, KARLA
|
STANFORD UNIVERSITY
|
CA
|
$323,648
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI068759-02
|
|
Mapping Autoimmune Phenotypes in Multiplex Families
|
GREGERSEN, PETER
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$783,262
|
|
Multiple Sclerosis
|
NINDS
|
1R01NS057194-01A2
|
|
Regulation of Autoimmune Encephalomyelitis
|
ZAGHOUANI, HABIB
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$314,919
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS048868-05
|
|
Mechanism of IGF-I actions on oligodendroglial cells
|
D'ERCOLE, A
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$341,531
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS034510-13
|
|
The Role of chemokines in Autoimmune Encephalomyelitis
|
KARPUS, WILLIAM
|
NORTHWESTERN UNIVERSITY
|
IL
|
$267,527
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI042396-11
|
|
Competition Among Pathogenic or Protective T Cell Clones
|
SERCARZ, ELI
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
CA
|
$380,902
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI045515-10
|
|
Stat4 Immunobiology
|
KAPLAN, MARK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$272,087
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI047249-08
|
|
Immune Regulation of CNS Viral Recrudescence
|
BERGMANN, CORNELIA
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$378,911
|
|
Multiple Sclerosis
|
NIGMS
|
5R01GM076063-03
|
|
Alkoxypsoralens, Small Molecule Blockers of the Voltage-Gated Kv1.3 Channel
|
WULFF, HEIKE
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$255,640
|
|
Multiple Sclerosis
|
NIAID
|
5R37AI033993-15
|
|
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
|
HUNT, DONALD
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$667,763
|
|
Multiple Sclerosis
|
NIGMS
|
5R01GM037751-22
|
|
Function and Regulation of Intercellular Communication
|
PAUL, DAVID
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$422,500
|
|
Multiple Sclerosis
|
NINDS
|
2R01NS030800-13
|
|
Development of Oligodendrycytes in the Spinal Cord
|
MILLER, ROBERT
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$337,969
|
|
Multiple Sclerosis
|
NCCAM
|
5K23AT002155-05
|
|
Fish oil for depression in multiple sclerosis
|
SHINTO, LYNNE
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$117,730
|
|
Multiple Sclerosis
|
NINDS
|
5K23NS048869-04
|
|
Correlating Multiple Sclerosis Phenotypes with Genotypes
|
CREE, BRUCE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$161,406
|
|
Multiple Sclerosis
|
NIAID
|
5R01AI049524-07
|
|
MHC proteins, copolymers and peptide 15mers in EAE
|
STROMINGER, JACK
|
HARVARD UNIVERSITY
|
MA
|
$409,568
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS052505-03
|
|
Diffusion Tensor Imaging of Wallerian Degeneration in MS
|
HASAN, KHADER
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$291,992
|
|
Multiple Sclerosis
|
NINDS
|
1R01NS048357-01A2
|
|
Genetic Analysis of Spontaneous Remyelination
|
BIEBER, ALLAN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$264,425
|
|
Multiple Sclerosis
|
NINDS
|
1R01NS058698-01A2
|
|
CD8+ T cells in formation of T1 black holes in animal model of multiple sclerosis
|
PIRKO, ISTVAN
|
UNIVERSITY OF CINCINNATI
|
OH
|
$307,125
|
|
Multiple Sclerosis
|
NIBIB
|
2R01EB002095-06A1
|
|
Automated MR Image Analysis in MS: Identification of a Surrogate
|
NARAYANA, PONNADA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$668,742
|
|
Multiple Sclerosis
|
NINDS
|
1R01NS057433-01A2
|
|
Mitochondrial modulation for neuroprotection in a model of multiple sclerosis
|
BOURDETTE, DENNIS
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$336,875
|
|
Multiple Sclerosis
|
NINDS
|
1R01NS057755-01A2
|
|
PROTEIN CARBONYLATION AND AXONAL DAMAGE IN EAE
|
BIZZOZERO, OSCAR
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$290,000
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS023022-22
|
|
Synthesis and Assembly of Basic Proteins into Myelin.
|
CAMPAGNONI, ANTHONY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$338,768
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS050389-04
|
|
Olig2 in Oligodendrocyte Myelination and Remyelination
|
LU, QING
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$342,057
|
|
Multiple Sclerosis
|
NIAID
|
2R01AI040614-11A1
|
|
In vivo role of CTLA-4 in Costimulation and Autoimmunity
|
SHARPE, ARLENE
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$422,500
|
|
Multiple Sclerosis
|
NIAID
|
2R01AI053439-05A2
|
|
ROLE OF T CELLS IN THE IMMUNE MODULATION OF MS
|
KARANDIKAR, NITIN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$104,667
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS036526-12
|
|
Susceptibilty and Resistance Loci in Mouse EAE
|
TEUSCHER, CORY
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$448,309
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS032830-14
|
|
Genetic Epidemiology of Multiple Sclerosis
|
HAINES, JONATHAN
|
VANDERBILT UNIVERSITY
|
TN
|
$846,841
|
|
Multiple Sclerosis
|
NINDS
|
7R21NS060311-02
|
|
DNA-Based Biomarkers for Multiple Sclerosis
|
LEVENSON, VICTOR
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$172,031
|
|
Multiple Sclerosis
|
NHLBI
|
1R01HL089934-01A1
|
|
Sphingosine 1-phosphate receptors in vascular homeostasis and pathology
|
HLA, TIMOTHY
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$370,000
|
|
Multiple Sclerosis
|
NEI
|
5K08EY015098-05
|
|
Prevention of Neuronal Damage in Optic Neuritis
|
SHINDLER, KENNETH
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$187,121
|
|
Multiple Sclerosis
|
NIAID
|
1R01AI069358-01A2
|
|
The Role of B Cells in Regulating Autoimmunity
|
DITTEL, BONNIE
|
BLOODCENTER OF WISCONSIN, INC.
|
WI
|
$400,000
|
|
Multiple Sclerosis
|
NINDS
|
5K08NS047669-04
|
|
Mechanisms of Neurodegeneration & Neuroprotection in EAE
|
CHITNIS, TANUJA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$175,176
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS051245-03
|
|
Treatment of EAE by Small Peptide Mimetics of SOCS-1
|
JOHNSON, HOWARD
|
UNIVERSITY OF FLORIDA
|
FL
|
$317,881
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS053487-04
|
|
Effects of Neuroinflammation on Gap Junction Communication in Glia
|
KIELIAN, TAMMY
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$289,043
|
|
Multiple Sclerosis
|
NIAID
|
1K08AI074913-01A1
|
|
Virus Detection Using Microarrays and Characterization of a Novel Cardiovirus
|
CHIU, CHARLES
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$124,040
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS051591-02
|
|
A Combination Trial of Copaxone Plus Estriol in RRMS
|
VOSKUHL, RHONDA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$500,000
|
|
Multiple Sclerosis
|
NCRR
|
5K01RR022198-03
|
|
Hormonal Modulation of DCs: Influences on Innate and Adaptive Immunity
|
PAPENFUSS, TRACEY
|
OHIO STATE UNIVERSITY
|
OH
|
$124,551
|
|
Multiple Sclerosis
|
NINDS
|
5F31NS056503-03
|
|
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM
|
RODRIGUEZ-MANZANET, ROSELYNN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$30,723
|
|
Multiple Sclerosis
|
NINDS
|
5F31NS058941-02
|
|
Regulation of polarized Th responses in EAE by lkaros
|
QUIRION, MARY
|
NORTHWESTERN UNIVERSITY
|
IL
|
$27,701
|
|
Multiple Sclerosis
|
NIAID
|
1R01AI073654-01A1
|
|
Recognition of Self and Mutated Self by Autoimmune and Tumor-Specific TCRs
|
MARIUZZA, ROY
|
UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE
|
MD
|
$405,000
|
|
Multiple Sclerosis
|
NINDS
|
1R01NS060822-01A1
|
|
Impact of social stress-induced cytokines on an animal model of MS
|
MEAGHER, MARY
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$251,749
|
|
Multiple Sclerosis
|
NINDS
|
1R01NS060807-01A1
|
|
Lipid hydroxylation in glial cell signaling and myelination
|
HAMA, HIROKO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$287,438
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS041972-05
|
|
Gender differences in immune responses in MS
|
RANSOHOFF, RICHARD
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$270,375
|
|
Multiple Sclerosis
|
NIAID
|
1K08AI075029-01A1
|
|
gC399tr an inhibitor of autoimmunity
|
MAVERAKIS, EMANUAL
|
EAST BAY INSTITUTE FOR RESEARCH AND EDUC
|
CA
|
$113,714
|
|
Multiple Sclerosis
|
NINDS
|
5R03NS056075-02
|
|
Creation of a fatty acid 2-hydoxylase-knockout mouse model
|
HAMA, HIROKO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$73,000
|
|
Multiple Sclerosis
|
NINDS
|
5R03NS061375-02
|
|
Regulatory cells involved in the suppression of active EAE
|
ITO, KOUICHI
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
NJ
|
$78,000
|
|
Multiple Sclerosis
|
NINDS
|
5K23NS052430-02
|
|
Diffusion Imaging of Axonal Loss in the Optic Nerves
|
NAISMITH, ROBERT
|
WASHINGTON UNIVERSITY
|
MO
|
$153,974
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS048435-05
|
|
Role of IL-12/IL-23 in Intravenous Tolerance
|
ROSTAMI, ABDOLMOHAMAD
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$317,280
|
|
Multiple Sclerosis
|
NIAMS
|
5R21AR054495-02
|
|
ROLE OF IL-23 IN PSORIASIS PATHOGENESIS
|
BLAUVELT, ANDREW
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$132,741
|
|
Multiple Sclerosis
|
NIAID
|
5R37AI044257-10
|
|
FDRC1 AND FOLLICULAR DENDRITIC CELL SIGNALING PATHWAYS
|
CLARK, EDWARD
|
UNIVERSITY OF WASHINGTON
|
WA
|
$334,861
|
|
Multiple Sclerosis
|
NINDS
|
5K23NS047211-05
|
|
Brain Atrophy/Diffusion Tensor Study/Multiple Sclerosis
|
FOX, ROBERT
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$169,503
|
|
Multiple Sclerosis
|
NINDS
|
5R37NS037096-27
|
|
Complex Carbohydrates in Neuronal Cell Function
|
SCHNAAR, RONALD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$395,630
|
|
Multiple Sclerosis
|
NINDS
|
5R21NS060307-02
|
|
Matrix metalloproteinases as biomarkers of neurodegeneration
|
SHUBAYEV, VERONICA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$193,125
|
|
Multiple Sclerosis
|
NINDS
|
1R43NS060188-01A1
|
|
Identification of Oligodendrocyte Stimulators
|
HOSONO, SEIYU
|
JS GENETICS, LLC
|
CT
|
$150,854
|
|
Multiple Sclerosis
|
NIAID
|
1F32AI075761-01A1
|
|
TGFBeta, IL-6 & IL-23 in induction of pathogenic vs. regulatory T cells in vivo
|
MITTAL, AKANKSHA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$50,476
|
|
Multiple Sclerosis
|
NINDS
|
2R44NS040205-04
|
|
Long Acting Beta Interferon for Treating Multiple Sclerosis - Phase II Continuing
|
COX, GEORGE
|
BOLDER BIOTECHNOLOGY, INC.
|
CO
|
$826,535
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS042194-07
|
|
Pre-diagnostic markers of infection and risk of MS
|
ASCHERIO, ALBERTO
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$359,598
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS052471-04
|
|
Synergy between T cells and Complement in EAE
|
LIN, FENG
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$237,137
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS037766-10
|
|
Cytokines in Glial Cells and EAE Brain
|
SINGH, INDERJIT
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$320,130
|
|
Multiple Sclerosis
|
NINDS
|
5K08NS055135-03
|
|
Axonal Protection by Myelin-Associated Glycoprotein (MAG)
|
NGUYEN, THIEN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$167,847
|
|
Multiple Sclerosis
|
NIAID
|
5R21AI077100-02
|
|
Mast cell regulation of CD8+ T cell responses
|
BROWN, MELISSA
|
NORTHWESTERN UNIVERSITY
|
IL
|
$185,164
|
|
Multiple Sclerosis
|
NINDS
|
5F32NS055631-03
|
|
Downstream Targets of Olig 2
|
MEHTA, SHWETAL
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$52,048
|
|
Multiple Sclerosis
|
NINDS
|
5R01NS050466-03
|
|
Magnetic Resonance Imaging in Myelin Disease and Repair
|
FIELD, AARON
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$321,158
|
|
Multiple Sclerosis
|
NCI
|
5R01CA075971-10
|
|
Statistical Methods for Analysis of Failure Time Data
|
BETENSKY, REBECCA
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$238,926
|
|
Multiple Sclerosis
|
NEI
|
5R01EY015557-03
|
|
Ocular HSV: Role of virus and IL-2 in Optic neuritis
|
GHIASI, HOMAYON
|
CEDARS-SINAI MEDICAL CENTER
|
CA
|
$325,429
|
|
Multiple Sclerosis
|
NINDS
|
5K02NS050102-03
|
|
The Role of Telomerase in Oligodendrocyte Proliferation
|
CAPORASO, GREGG
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$168,180
|
|
Multiple Sclerosis
|
NCCAM
|
5K23AT003258-04
|
|
Lipoic acid as an immune modulator in multiple sclerosis
|
YADAV, VIJAYSHREE
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$133,920
|
|
Multiple Sclerosis
|
NIAMS
|
5R03AR054909-02
|
|
Dissecting the protective and pathogenic functions of TNF alpha in SLE
|
RAMANUJAM, MEERA
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$81,176
|
|
Multiple Sclerosis
|
NICHD
|
5K01HD049476-03
|
|
MECHANISMS OF LOCOMOTOR RECOVERY IN MULTIPLE SCLEROSIS
|
ZACKOWSKI, KATHLEEN
|
HUGO W. MOSER RES INST KENNEDY KRIEGER
|
MD
|
$102,298
|
|
Multiple Sclerosis
|
NINDS
|
5K23NS052557-03
|
|
Use of Two DBS Electrodes to Treat Post-Traumatic Tremor
|
FOOTE, KELLY
|
UNIVERSITY OF FLORIDA
|
FL
|
$160,477
|
|
Multiple Sclerosis
|
NIGMS
|
5R01GM063074-07
|
|
Molecular Organization and Function of Paranodal Axo-Glial Junctions
|
BHAT, MANZOOR
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$297,604
|
|
Multiple Sclerosis
|
NIGMS
|
5R01GM020964-34
|
|
Genetics and Regulation of Autoantibodies
|
WEIGERT, MARTIN
|
UNIVERSITY OF CHICAGO
|
IL
|
$565,315
|
|
Multiple Sclerosis
|
NCCAM
|
5R21AT004349-02
|
|
Mechanism of Modulation of Interleukin-12 Production by Triptolide
|
MA, XIAOJING
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$192,629
|
|
Multiple Sclerosis
|
NINDS
|
5R44NS052920-03
|
|
Novel Therapy for Multiple Sclerosis (SBIR-Phase II)
|
LI, FENG-QIAO
|
COGNOSCI, INC.
|
NC
|
$198,514
|
|
Multiple Sclerosis
|
NCRR
|
5K24RR021948-04
|
|
Treatment of Multiple Sclerosis
|
REDER, ANTHONY
|
UNIVERSITY OF CHICAGO
|
IL
|
$145,465
|
|
Multiple Sclerosis
|
NIMH
|
5K08MH072724-04
|
|
Depression and executive function in multiple sclerosis
|
JULIAN, LAURA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$160,608
|
|
